Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.
We have previously found that approximately 3.5% of 428 clinical isolates of Mycobacterium tuberculosis yield uninterpretable results in the BACTEC pyrazinamide (PZA) susceptibility test system, because of inadequate growth. We tested the hypothesis that polyoxyethylene stearate (POES), the ingredie...
Na minha lista:
| Publicado no: | J Clin Microbiol |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1996
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC228736/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8748279/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.34.1.84-86.1996 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
